Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. New Zealand
  4. New Zealand Stock Exchange
  5. TruScreen Group Limited
  6. News
  7. Summary
    TRU   NZTRUE0001S7

TRUSCREEN GROUP LIMITED

(TRU)
  Report
End-of-day quote. End-of-day quote New Zealand Stock Exchange - 08/03
0.064 NZD   0.00%
07/08TRUSCREEN : Director Nominations Closing Date
PU
07/01TRUSCREEN : First Sales Made in Eastern Europe
PU
06/30TRUSCREEN : to Ship Cervical Cancer Screening Devices to Serbia in July
MT
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

TruScreen : Board Appointment

03/01/2021 | 09:53pm EDT
Truscreen Group Limited (NZX and ASX:TRU) (TruScreen or Company) is pleased to announce the appointment of Dr. Dexter Cheung as a non-executive director of TruScreen.Dr. Cheung is an experienced medical device engineer and specialist in product research and development, with more than 20 years' experience. He is the Research & Development Manager of the respiratory humidification division of Fisher & Paykel Healthcare, an NZX/ASX listed healthcare company and a global leader in respiratory medical devices.

Dr Cheung's technical background in opto-electronics and expertise in medical device engineering is highly relevant to TruScreen whose cervical cancer screening device harnesses optical and electrical signatures for screening results.

Dr Cheung brings a strong understanding of manufacturing processes and has travelled extensively to China, USA, Europe, United Kingdom and Japan working closely with medical device manufacturers and component suppliers in these regions.

Dr Cheung has published eight papers and has eight international patents pending or granted jointly with collaborators or in his name, focusing on respiratory air flow management. He has previously served on a visiting committee of the Auckland University of Technology.

Dr. Cheung holds a first-class honours degree in Bachelor of Technology, a Master of Engineering (first class honours) degree and a Doctor of Philosophy (in physics) from his alma mater, University of Auckland.

Mr. Chris Lawrence has also announced his retirement from the board due to health reasons. Shareholders would recall that Mr. Lawrence was unable to attend the last annual shareholders general meeting in August 2020 for health reasons.

Tony Ho, Chairman commented'On behalf of the board, I thank Chris Lawrence for his unstinting contributions to the board over the past four years.

'The directors are pleased to welcome Dr. Dexter Cheung to the Board of TruScreen. He brings very relevant technical and product development experience with a major global healthcare firm, along with the business experience and manufacturing expertise within our key markets of China and Central America. This skill set will assist TruScreen as we continue to evolve and scale up.'

Disclaimer

TruScreen Limited published this content on 02 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 02 March 2021 02:52:08 UTC.


ę Publicnow 2021
All news about TRUSCREEN GROUP LIMITED
07/08TRUSCREEN : Director Nominations Closing Date
PU
07/01TRUSCREEN : First Sales Made in Eastern Europe
PU
06/30TRUSCREEN : to Ship Cervical Cancer Screening Devices to Serbia in July
MT
06/01TRUSCREEN : FY21 Preliminary Results
PU
03/24TRUSCREEN : Research Confirms TruSreeen Suitability in COVID-19 Environment
PU
03/23TRUSCREEN : Cervical Cancer Screening Device Suitable for COVID-19 Environment
MT
03/01TRUSCREEN : Board Appointment
PU
03/01TruScreen Group Limited Announces Board Changes
CI
02/25TRUSCREEN : Executive Leadership Change
PU
02/25TruScreen Group Limited Announces Executive Changes
CI
More news
Financials
Sales 2021 1,97 M 1,38 M 1,38 M
Net income 2021 -3,49 M -2,44 M -2,44 M
Net cash 2021 5,26 M 3,68 M 3,68 M
P/E ratio 2021 -9,18x
Yield 2021 -
Capitalization 23,2 M 16,3 M 16,3 M
EV / Sales 2020 6,02x
EV / Sales 2021 15,5x
Nbr of Employees -
Free-Float 69,8%
Chart TRUSCREEN GROUP LIMITED
Duration : Period :
TruScreen Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts
Last Close Price 0,06 
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Juliet Hull Chief Executive Officer & Director
Guy Robertson Chief Financial Officer & Secretary
Peng Ho Non-Executive Chairman
Edmond Capcelea Chief Technology Officer
Nicole Melia Manager-Administration & Marketing
Sector and Competitors